The first Czech-grown medical cannabis reaches distribution

On 22 March 2016, the first medical cannabis grown inside Czechia became available to the pharmacy distribution network. It was an implementation milestone in a system that had been legal since 2013 but was designed to begin with imported supply.

A system built in stages

The government’s 2013 summary of the new medical law explained that patients would obtain cannabis only from pharmacies and only by prescription. Individual medical growing was not permitted. Imports could begin under Ministry of Health supervision while the domestic licensing and procurement system was prepared.

Parts of the law dealing with cultivation, grower selection, processing and transport were delayed until 1 April 2014. SÚKL, acting as the national medical-cannabis agency, was charged with establishing the system and licensing a producer that also held the necessary controlled-substance authorisation.

The first Czech crop

SÚKL announced in March 2016 that it had taken ownership of the first portion grown under its public contract by Elkoplast Slušovice. From that day, the batch was available in the distribution network and could move onward to pharmacies.

The agency identified it as Cannabis sativa containing 19% THC and less than 1% CBD. Those figures described this particular batch; they were not a general potency rule for all medical cannabis.

What domestic supply changed

The arrival of a Czech crop did not legalise a new activity for patients. The 2013 reform had already created the prescription right, and medical cannabis still had to pass through doctors, pharmacies and the restricted distribution system. Home cultivation for a medical purpose remained outside that programme.

What changed was the source of regulated stock. The country no longer depended exclusively on imported cannabis for its legal medical channel. The state-contracted model itself would later be replaced: from 2022, any applicant satisfying the statutory conditions could seek a cultivation licence.

What moved in the index

Nothing moved in the Cannabis Freedom Index. Domestic production strengthened implementation and supply, but patients already had legal medical access. The access score therefore stayed at 1, while this event records how the system described in the Czechia profile began to obtain locally grown medicine.^[1][2]